JERSEY CITY, N.J.--(BUSINESS WIRE)--July 11, 2006--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, today announced the appointment of David R. Guyer, MD, venture partner, SV Life Sciences Advisers, to its Board of Directors.
